EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of a Novel High‐Sensitivity Multiplex Companion Diagnostic Test Using Formalin‐Fixed Paraffin‐Embedded Cell Block Materials of Non‐small Cell Lung Cancer

Yoshiki Shinomiya iD, Yuko Ishida, Kanako C Hatanaka, Mayumi Yamamoto, Ayae Nange, Asami Okumura, Yumi Wada, Mitsuharu Abiko, Tomohiro Shimizu, Ryoko Watanabe, Yamato Hashimoto, Yoshiharu Sato und 4 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.71028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yoshiki Shinomiya und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Formalin‐fixed paraffin‐embedded (FFPE) tissue is the standard material for companion diagnostic tests (CDx). Although cytological specimens can be useful, their low tumor content (TC) poses challenges. Recently, a high‐sensitivity CDx, the “Lung Cancer Compact Panel (cPANEL),” with a recommended TC of 5%, was introduced into clinical practice. This CDx achieves high detection sensitivity by selecting specific genes for analysis, processing them separately, and performing sequence at sufficient depth. This approach enables the detection of mutations even when they are present in only small amounts within the sample. This study aimed to evaluate the utility of cPANEL using FFPE cell block (CB) with a low TC.

Methods

We analyzed FFPE‐CB pleural fluid samples from 26 patients diagnosed with malignant pleural effusion originating from lung adenocarcinoma. TC was quantified using AI‐equipped image analysis software, and samples with a TC of less than 10%—the minimum threshold for single‐CDx—were selected for CDx analysis. To confirm that cPANEL has better sensitivity than single‐CDx, which has high detection power, and that it is advantageous in low TC samples such as FFPE‐CB, we compared the two CDx assays based on the EGFR‐positive rate using samples that did not meet the TC criterion for single‐CDx.

Results

Most FFPE‐CB had low TC levels, with only approximately 27% meeting the TC criteria for the widely used multi‐CDx. Furthermore, over 60% of the samples fell below the 10% threshold for a single‐CDx. Despite the low TC, EGFR mutations were partially detected, with cPANEL achieving a higher detection rate than that of single‐CDx (68.8% vs. 50.0%).

Conclusions

Although cPANEL is classified as a multi‐CDx, it demonstrated superior sensitivity compared with that of single‐CDx. It proved effective even for FFPE‐CB samples with very low TC, making it a promising tool to enhance the use of cytological samples for CDx in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungBiomarkers, TumorHumansParaffin EmbeddingFormaldehydeTissue FixationFemaleMaleMutationAgedMiddle AgedPleural Effusion, MalignantErbB ReceptorsSensitivity and Specificity

Stichwörter der Autor:innen

EGFRcytologynext‐generation sequencingnon‐small cell lung cancertumor content

Substanzen

FormaldehydeErbB ReceptorsBiomarkers, TumorEGFR protein, human

Autor:innen und Institutionen

  • Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan.
  • Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
  • DNA Chip Research Inc., Kawasaki, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Medical Network and Welfare Center, Hokkaido University Hospital, Sapporo, Japan.
  • Department of Thoracic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

ORCID-Profile: Yoshiki Shinomiya, Jun Sakakibara-Konishi

Zitieren

APA

Shinomiya, Y., Ishida, Y., Hatanaka, K. C., Yamamoto, M., Nange, A., Okumura, A., Wada, Y., Abiko, M., Shimizu, T., Watanabe, R., Hashimoto, Y., Sato, Y., Sakakibara-Konishi, J., Kato, T., Tanaka, S., & Hatanaka, Y. (2025). Utility of a Novel High‐Sensitivity Multiplex Companion Diagnostic Test Using Formalin‐Fixed Paraffin‐Embedded Cell Block Materials of Non‐small Cell Lung Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71028

Vancouver

Shinomiya Y, Ishida Y, Hatanaka KC, Yamamoto M, Nange A, Okumura A, et al. Utility of a Novel High‐Sensitivity Multiplex Companion Diagnostic Test Using Formalin‐Fixed Paraffin‐Embedded Cell Block Materials of Non‐small Cell Lung Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71028

BibTeX
@article{Shinomiya2025,
  author = {Shinomiya, Yoshiki and Ishida, Yuko and Hatanaka, Kanako C and Yamamoto, Mayumi and Nange, Ayae and Okumura, Asami and Wada, Yumi and Abiko, Mitsuharu and Shimizu, Tomohiro and Watanabe, Ryoko and Hashimoto, Yamato and Sato, Yoshiharu and Sakakibara-Konishi, Jun and Kato, Tatsuya and Tanaka, Shinya and Hatanaka, Yutaka},
  title = {Utility of a Novel High‐Sensitivity Multiplex Companion Diagnostic Test Using Formalin‐Fixed Paraffin‐Embedded Cell Block Materials of Non‐small Cell Lung Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71028}
}
Kostenlos starten →